http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1778882-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_919bb13d9909c59407f6b66355f39b02 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-445 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-445 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-04 |
| filingDate | 2005-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6646af5a0a60c29b9833d195d91005f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_500f4871cedc270389c6d30ce9eedc7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1c6773d35bdfe444f81f47939c438b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f79dd70f78c2df3df0bc70424c28e96d |
| publicationDate | 2007-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1778882-A2 |
| titleOfInvention | Novel bacteria and pharmaceutically active products obtained therefrom |
| abstract | A substance obtainable from Staphylococcus Aureus bacteria or from a Staphylococcus Aureus bacteria culture, the substance characterized in having at least one of the following characteristics: (a) stimulates proliferation of bovine T-lymphocytes in vitro; (b) accelerates healing of skin wounds in mice and pigs; (c) prevents AIDS-like disease (ALD) in mice infected with ALD virus (ALD-V) when injected substantially simultaneously with the virus; and (d) reduces the viral load in Rhesus Macaques infected with the hybrid simian/human immunodeficiency virus (SHIV) when injected into chronically infected Macaques, or a derivative or fraction of said substance which retains at least one of the characteristics of the substance. Also disclosed is a novel Staphylococcus Aureus bacteria, and a pharmaceutical composition comprising as active ingredient the substance and a pharmaceutically acceptable excipient. |
| priorityDate | 2004-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 437.